Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.53% |
| 2 | Financials | 13.97% |
| 3 | Healthcare | 13.42% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STFC
2101
DELISTED
State Auto Financial Corp
STFC
| $16.2M | ﹤0.01% |
318,509
+6,453
| +2% | +$306K |
|
2102
Axsome Therapeutics
AXSM
$11.2B
| $16.2M | ﹤0.01% |
491,430
+8,180
| +2% | +$319K |
|
2103
Agilon Health
AGL
$1.49B
| $16.2M | ﹤0.01% |
24,672
+2,806
| +13% | +$2.4M |
|
2104
Origin Bancorp
OBK
$1.69B
| $16.2M | ﹤0.01% |
381,616
+3,800
| +1% | +$156K |
|
2105
Monarch Casino & Resort
MCRI
$2.2B
| $16.2M | ﹤0.01% |
241,099
+1,281
| +0.5% | +$82.8K |
|
2106
Madrigal Pharmaceuticals
MDGL
$11.7B
| $16.1M | ﹤0.01% |
202,375
+4,271
| +2% | +$369K |
|
2107
New Fortress Energy
NFE
$93M
| $16.1M | ﹤0.01% |
581,805
-69,060
| -11% | -$2.08M |
|
2108
BioNTech
BNTX
$23.1B
| $16.1M | ﹤0.01% |
58,924
+1,860
| +3% | +$591K |
|
2109
MGP Ingredients
MGPI
$389M
| $16.1M | ﹤0.01% |
246,935
+2,270
| +0.9% | +$145K |
|
|
PWSC
2110
DELISTED
PowerSchool Holdings, Inc.
PWSC
| $16M | ﹤0.01% |
+651,995
| New | +$18.1M |
|
|
QADA
2111
DELISTED
QAD Inc.
QADA
| $16M | ﹤0.01% |
183,610
-7,013
| -4% | -$611K |
|
|
TBI
2112
Trueblue
TBI
$309M
| $16M | ﹤0.01% |
592,011
-1,350
| -0.2% | -$36.1K |
|
|
PTRA
2113
DELISTED
Proterra Inc. Common Stock
PTRA
| $16M | ﹤0.01% |
1,585,279
+1,451,839
| +1,088% | +$16.4M |
|
2114
Vaxcyte
PCVX
$8.76B
| $16M | ﹤0.01% |
630,567
+111,593
| +22% | +$2.7M |
|
|
CCXI
2115
DELISTED
ChemoCentryx, Inc.
CCXI
| $16M | ﹤0.01% |
935,419
+36,681
| +4% | +$572K |
|
2116
TFS Financial
TFSL
$4.93B
| $16M | ﹤0.01% |
838,772
+24,679
| +3% | +$481K |
|
|
CVAC
2117
DELISTED
CureVac
CVAC
| $16M | ﹤0.01% |
292,287
+8,470
| +3% | +$510K |
|
2118
Ryan Specialty Holdings
RYAN
$11B
| $15.9M | ﹤0.01% |
+470,793
| New | +$14.8M |
|
|
VIVO
2119
DELISTED
Meridian Bioscience Inc
VIVO
| $15.9M | ﹤0.01% |
828,723
-102,580
| -11% | -$2.04M |
|
2120
Benchmark Electronics
BHE
$2.89B
| $15.9M | ﹤0.01% |
595,210
+1,056
| +0.2% | +$28K |
|
2121
Kearny Financial
KRNY
$604M
| $15.9M | ﹤0.01% |
1,278,741
+23,259
| +2% | +$287K |
|
2122
Marqeta
MQ
$1.71B
| $15.9M | ﹤0.01% |
179,581
+173,179
| +2,705% | +$18.5M |
|
|
MCHB
2123
Mechanics Bancorp
MCHB
$3.79B
| $15.9M | ﹤0.01% |
385,543
+8,137
| +2% | +$318K |
|
2124
SentinelOne
S
$8.17B
| $15.8M | ﹤0.01% |
+295,387
| New | +$16.2M |
|
2125
Myers Industries
MYE
$1.25B
| $15.8M | ﹤0.01% |
805,880
+964
| +0.1% | +$20.5K |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.